Melatonin and tryptophan circadian profiles in patients with advanced non-small cell lung cancer

Advances in Therapy

Volumn 26, Issue 9, 2009, Pages 886-892

  Hu, Shilian ^a   Shen, Gan ^a   Yin, Shi ^a   Xu, Weiping ^a   Hu, Bing ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

6 sulfatoxymelatonin; Circadian rhythm; Melatonin; Non small cell lung cancer; Tryptophan

Indexed keywords

6 HYDROXYMELATONIN O SULFATE; CISPLATIN; MELATONIN; NAVELBINE; TRYPTOPHAN;

ADULT; ADVANCED CANCER; ARTICLE; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE BLOOD LEVEL; HUMAN; LUNG NON SMALL CELL CANCER; MALE; MULTIPLE CYCLE TREATMENT; URINALYSIS;

AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; CIRCADIAN RHYTHM; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MELATONIN; MIDDLE AGED; TRYPTOPHAN;

EID: 76749103740     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12325-009-0068-8     Document Type: Article

References (27)

1. D.P. Cardinali D.A. Golombek R.E. Rosenstein R.A. Cutrera A.I. Esquifino 1997 Melatonin site and mechanism of action: single or multiple J Pineal Res 23 32 39 10.1111/j.1600-079X.1997.tb00332.x 1:CAS:528:DyaK2sXmt1Oqu7s%3D 9379344
2. M. Abe M.T. Itoh M. Miyata S. Ishikawa Y. Sumi 1999 Detection of melatonin, its precursors and related enzyme activities in rabbit lens Exp Eye Res 68 255 262 10.1006/exer.1998.0601 1:CAS:528:DyaK1MXhsFajurc%3D 10068491 (Pubitemid 29090639)
3. B. Jung N. Ahmad 2006 Melatonin in cancer management: progress and promise Cancer Res 66 9789 9793 10.1158/0008-5472.CAN-06-1776 1:CAS:528:DC%2BD28XhtVyiurzI 17047036 (Pubitemid 44672026)
4. A. Carrillo-Vico J.M. Guerrero P.J. Lardone R.J. Reiter 2005 A review of the multiple actions of melatonin on the immune system Endocrine 27 189 200 10.1385/ENDO:27:2:189 1:CAS:528:DC%2BD2MXhtFansLnL 16217132 (Pubitemid 41558451)
5. C. Bartsch H. Bartsch 2006 The anti-tumor activity of pineal melatonin and cancer enhancing life styles in industrialized societies Cancer Causes Control 17 559 571 10.1007/s10552-005-9011-8 16596311
6. L.E. Carlson T.S. Campbell S.N. Garland P. Grossman 2007 Associations among salivary cortisol, melatonin, catecholamines, sleep quality and stress in women with breast cancer and healthy controls J Behav Med 30 45 58 10.1007/s10865-006-9082-3 17245618 (Pubitemid 46197887)
7. T. Ravindra N.K. Lakshmi Y.R. Ahuja 2006 Melatonin in pathogenesis and therapy of cancer Indian J Med Sci 60 523 535 10.4103/0019-5359.28983 1:STN:280:DC%2BD28nptF2jsQ%3D%3D 17130668
8. C. Nagata Y. Nagao S. Yamamoto C. Shibuya Y. Kashiki H. Shimizu 2008 Light exposure at night, urinary 6-sulfatoxymelatonin, and serum estrogens and androgens in postmenopausal Japanese women Cancer Epidemiol Biomarkers Prev 17 1418 1423 10.1158/1055-9965.EPI-07-0656 1:CAS:528:DC%2BD1cXnsVKgtLg%3D 18559557
9. E.S. Schernhammer F. Berrino V. Krogh 2008 Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal women J Natl Cancer Inst 100 898 905 10.1093/jnci/djn171 1:CAS:528:DC%2BD1cXnsF2qurw%3D 18544743 (Pubitemid 351881952)
10. A.H. Wu R. Wang W.P. Koh F.Z. Stanczyk H.P. Lee M.C. Yu 2008 Sleep duration, melatonin and breast cancer among Chinese women in Singapore Carcinogenesis 29 1244 1248 10.1093/carcin/bgn100 1:CAS:528:DC%2BD1cXot1Wjsb8%3D 18448486 (Pubitemid 351958705)
11. C.W. Tam K.W. Chan V.W. Liu B. Pang K.M. Yao S.Y. Shiu 2008 Melatonin as a negative mitogenic hormonal regulator of human prostate epithelial cell growth: potential mechanisms and clinical significance J Pineal Res 45 403 412 10.1111/j.1600-079X.2008.00608.x 1:CAS:528:DC%2BD1cXhtlKhsr%2FM 18637986
12. M. Karasek A.J. Kowalski J. Suzin K. Zylinska J. Swietoslawski 2005 Serum melatonin circadian profiles in women suffering from cervical cancer J Pineal Res 39 73 76 10.1111/j.1600-079X.2005.00221.x 1:CAS:528:DC%2BD2MXmsVegsbo%3D 15978060 (Pubitemid 40966465)
13. R. Aldeghi P. Lissoni S. Barni 1994 Low-dose interleukin-2 subcutaneous immunotherapy in association with the pineal hormone melatonin as a first-line therapy in locally advanced or metastatic hepatocellular carcinoma Eur J Cancer 30A 167 170 10.1016/0959-8049(94)90080-9 1:STN:280:DyaK2c3gs1KgtA%3D%3D 8155391 (Pubitemid 24081282)
14. S. Barni P. Lissoni M. Cazzaniga 1995 A randomized study of low-dose subcutaneous interleukin-2 plus melatonin versus supportive care alone in metastatic colorectal cancer patients progressing under 5-fluorouracil and folates Oncology 52 243 245 10.1159/000227465 1:STN:280:DyaK2M3jtFynuw%3D%3D 7715908
15. R. Dziadziuszko F.R. Hirsch 2008 Advances in genomic and proteomic studies of non-small-cell lung cancer: clinical and translational research perspective Clin Lung Cancer 9 78 84 10.3816/CLC.2008.n.012 18501093 (Pubitemid 351631919)
16. A. Motoyama T. Kanda R. Namba 2004 Direct determination of endogenous melatonin in human saliva by column-switching semi-microcolumn liquid chromatography/mass spectrometry with on-line analyte enrichment Rapid Commun Mass Spectrom 18 1250 1258 10.1002/rcm.1473 1:CAS:528:DC%2BD2cXlt1KlsLg%3D 15174178 (Pubitemid 38843146)
17. K. Eriksson A. Ostin J.O. Levin 2003 Quantification of melatonin in human saliva by liquid chromatographytandem mass spectrometry using stable isotope dilution J Chromatogr B Analyt Technol Biomed Life Sci 794 115 123 10.1016/S1570-0232(03)00425-2 1:CAS:528:DC%2BD3sXlvVCms7w%3D 12888204 (Pubitemid 36897632)
18. M. Muc-Wierzgon E. Nowakowska-Zajdel B. Zubelewicz 2003 Circadian fluctuations of melatonin, tumor necrosis factor-alpha and its soluble receptors in the circulation of patients with advanced gastrointestinal cancer J Exp Clin Cancer Res 22 171 178 1:CAS:528:DC%2BD3sXls1Gjur0%3D 12866566
19. C. Bartsch H. Bartsch U. Fuchs T.H. Lippert O. Bellmann D. Gupta 1989 Stage-dependent depression of melatonin in patients with primary breast cancer. Correlation with prolactin, thyroid stimulating hormone, and steroid receptors Cancer 64 426 433 10.1002/1097-0142(19890715)64:2<426::AID- CNCR2820640215>3.0.CO;2-O 1:STN:280:DyaL1M3osl2ktg%3D%3D 2736489
20. C. Bartsch H. Bartsch O. Bellmann T.H. Lippert 1991 Depression of serum melatonin in patients with primary breast cancer is not due to an increased peripheral metabolism Cancer 67 1681 1684 10.1002/1097-0142(19910315)67: 6<1681::AID-CNCR2820670634>3.0.CO;2-0 1:STN:280:DyaK3M7lvF2ntg%3D%3D 2001558
21. M. Barba A. Cavalleri H.J. Schunemann 2006 Reliability of urinary 6-sulfatoxymelatonin as a biomarker in breast cancer Int J Biol Markers 21 242 245 1:CAS:528:DC%2BD2sXis1Ojt7s%3D 17177163
22. R.C. Travis D.S. Allen I.S. Fentiman T.J. Key 2004 Melatonin and breast cancer: a prospective study J Natl Cancer Inst 96 475 482 1:CAS:528: DC%2BD2cXitlyiu70%3D 15026473
23. B. Kos-Kudla Z. Ostrowska A. Kozlowski 2002 Circadian rhythm of melatonin in patients with colorectal carcinoma Neuro Endocrinol Lett 23 239 242 1:CAS:528:DC%2BD38XlvVKntro%3D 12080285
24. M.J. Tisdale 2009 Mechanisms of cancer cachexia Physiol Rev 89 381 410 10.1152/physrev.00016.2008 1:CAS:528:DC%2BD1MXkvFegu74%3D 19342610
25. L. Lai L. Yuan Q. Chen 2008 The Galpha(i) and Galpha(q) proteins mediate the effects of melatonin on steroid/thyroid hormone receptor transcriptional activity and breast cancer cell proliferation J Pineal Res 45 476 488 10.1111/j.1600-079X.2008.00620.x 1:CAS:528:DC%2BD1cXhtlKhsr%2FE 18705646
26. P. Dziegiel M. Podhorska-Okolow M. Zabel 2008 Melatonin: adjuvant therapy of malignant tumors Med Sci Monit 14 RA64 RA70 1:CAS:528:DC%2BD1cXnvVSjtb0%3D 18443563
27. B.B. Otalora J.A. Madrid N. Alvarez V. Vicente M.A. Rol 2008 Effects of exogenous melatonin and circadian synchronization on tumor progression in melanoma-bearing C57BL6 mice J Pineal Res 44 307 315 10.1111/j.1600-079X.2007. 00531.x 1:CAS:528:DC%2BD1cXks1ansb4%3D 18339126